{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:13:57Z","timestamp":1784747637304,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001802","name":"University of Canberra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.thromres.2024.01.003","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T19:50:06Z","timestamp":1704570606000},"page":"120-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"234","author":[{"given":"Ann-Rong","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Samarawickrema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Naunton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2024.01.003_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"151","key":"10.1016\/j.thromres.2024.01.003_bb0010","article-title":"Cancer-associated thrombosis: the when, how and why","volume":"28","author":"Caio","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.thromres.2024.01.003_bb0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12885-020-06930-1","article-title":"Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study","volume":"20","author":"Howlett","year":"2020","journal-title":"BMC Cancer"},{"issue":"16","key":"10.1016\/j.thromres.2024.01.003_bb0020","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.thromres.2024.01.003_bb0025","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/jth.14564","article-title":"The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: guidance from the SSC of the ISTH","volume":"17","author":"Wang","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2024.01.003_bb0030","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.thromres.2024.01.003_bb0035","article-title":"Risk factors and prediction models for venous thromboembolism in ambulatory patients with lung cancer","volume":"9","author":"Yan","year":"2021","journal-title":"Healthcare (Switzerland)"},{"issue":"10","key":"10.1016\/j.thromres.2024.01.003_bb0040","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2024.01.003_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","article-title":"A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score","volume":"7","author":"Verso","year":"2012","journal-title":"Intern. Emerg. Med."},{"issue":"41","key":"10.1016\/j.thromres.2024.01.003_bb0050","first-page":"2084","article-title":"Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?","volume":"138","author":"Pelzer","year":"2013","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"10","key":"10.1016\/j.thromres.2024.01.003_bb0055","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS\u2013cancer-associated thrombosis study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.thromres.2024.01.003_bb0060","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3324\/haematol.2018.209114","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"104","author":"Frits","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.thromres.2024.01.003_bb0065","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.thromres.2024.01.003_bb0070","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/jth.14824","article-title":"The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta-analysis","volume":"18","author":"van Es","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2024.01.003_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12032-018-1120-9","article-title":"Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients","volume":"35","author":"Rupa-Matysek","year":"2018","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.003_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010050","article-title":"Dynamic thromboembolic risk modelling to target appropriate preventative strategies for patients with non-small cell lung cancer","volume":"11","author":"Alexander","year":"2019","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.thromres.2024.01.003_bb0085","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol."},{"issue":"24","key":"10.1016\/j.thromres.2024.01.003_bb0090","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2024.01.003_bb0095","first-page":"3755","article-title":"Development of a clinical prediction tool for cancer-associated venous thromboembolism (CAT): the MD Anderson Cancer Center CAT model","volume":"28","author":"Rojas-Hernandez","year":"2020","journal-title":"Support. Care Cancer"},{"issue":"12","key":"10.1016\/j.thromres.2024.01.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055322","article-title":"Models for predicting venous thromboembolism in ambulatory patients with lung cancer: a systematic review protocol","volume":"11","author":"Yan","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.thromres.2024.01.003_bb0105","unstructured":"Covidence. Available: https:\/\/www.covidence.org\/."},{"key":"10.1016\/j.thromres.2024.01.003_bb0110","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"1","key":"10.1016\/j.thromres.2024.01.003_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.003_bb0120","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.thromres.2024.01.003_bb0125","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3348\/kjr.2015.16.6.1188","article-title":"Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part II. Statistical methods of meta-analysis","volume":"16","author":"Lee","year":"2015","journal-title":"Korean J. Radiol."},{"issue":"6","key":"10.1016\/j.thromres.2024.01.003_bb0130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cllc.2012.03.005","article-title":"Novel high-sensitive d-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients","volume":"13","author":"Ferroni","year":"2012","journal-title":"Clin. Lung Cancer"},{"issue":"9","key":"10.1016\/j.thromres.2024.01.003_bb0135","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jth.13378","article-title":"Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer","volume":"14","author":"Mansfield","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"25","key":"10.1016\/j.thromres.2024.01.003_bb0140","doi-asserted-by":"crossref","first-page":"41412","DOI":"10.18632\/oncotarget.17916","article-title":"The relationship between tumor markers and pulmonary embolism in lung cancer","volume":"8","author":"Xiong","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.thromres.2024.01.003_bb0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1634\/theoncologist.2017-0205","article-title":"Predictors of venous thromboembolism and early mortality in lung cancer: results from a global prospective study (CANTARISK)","volume":"23","author":"Kuderer","year":"2018","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.thromres.2024.01.003_bb0150","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1634\/theoncologist.2017-0530","article-title":"Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer-associated thrombosis: the observational ROADMAP-CAT study","volume":"23","author":"Syrigos","year":"2018","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.thromres.2024.01.003_bb0155","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/1076029618777153","article-title":"Khorana score: \u03bdew predictor of early mortality in patients with lung adenocarcinoma","volume":"24","author":"Vathiotis","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2024.01.003_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.thromres.2020.09.021","article-title":"High plasma levels of soluble P-selectin and factor VIII predict venous thromboembolism in non-small cell lung cancer patients: the thrombo-Nsclc risk score","volume":"196","author":"Castell\u00f3n Rubio","year":"2020","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.003_bb0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/crj.13092","article-title":"Association between the Khorana score and pulmonary embolism risk in patients with advanced stage lung cancer","volume":"14","author":"Dapkevi\u010di\u016bt\u0117","year":"2020","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.thromres.2024.01.003_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1076029620910793","article-title":"Development and validation of a risk score for prediction of venous thromboembolism in patients with lung cancer","volume":"26","author":"Li","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"7","key":"10.1016\/j.thromres.2024.01.003_bb0175","doi-asserted-by":"crossref","first-page":"e1083","DOI":"10.1634\/theoncologist.2019-0482","article-title":"External validation of a venous thromboembolic risk score for cancer outpatients with solid tumors: the COMPASS-CAT venous thromboembolism risk assessment model","volume":"25","author":"Spyropoulos","year":"2020","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.thromres.2024.01.003_bb0180","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jth.15272","article-title":"Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors","volume":"19","author":"Icht","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.01.003_bb0185","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s11239-021-02396-5","article-title":"A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer","volume":"52","author":"Li","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2024.01.003_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.thromres.2021.10.013","article-title":"Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer","volume":"208","author":"Li","year":"2021","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.003_bb0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bjh.17476","article-title":"Thromboembolic risk in patients with lung cancer receiving systemic therapy","volume":"194","author":"Madison","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.003_bb0200","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-022-02649-x","article-title":"Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors","volume":"54","author":"Alma","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"issue":"10","key":"10.1016\/j.thromres.2024.01.003_bb0205","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/bloodadvances.2021006484","article-title":"Validation of the Khorana score for predicting venous thromboembolism in 40\u00a0218 patients with cancer initiating chemotherapy","volume":"6","author":"Overvad","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2024.01.003_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.33678\/cor.2021.126","article-title":"The role of the CHA2DS2-VASc score as a venous thromboembolism predictor in cancer patients","volume":"64","author":"\u015eahan","year":"2022","journal-title":"Cor Vasa"},{"issue":"1","key":"10.1016\/j.thromres.2024.01.003_bb0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-022-01259-7","article-title":"A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study","volume":"15","author":"Tsubata","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.003_bb0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10147-022-02257-y","article-title":"Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective rising-VTE\/NEJ037 study data","volume":"28","author":"Tsubata","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.thromres.2024.01.003_bb0225","first-page":"1","article-title":"The diagnostic value of the systemic immune-inflammation index for venous thromboembolism in lung cancer patients: a retrospective study","volume":"2022","author":"Zhang","year":"2022","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.thromres.2024.01.003_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006072","article-title":"Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer","volume":"11","author":"Khorana","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.thromres.2024.01.003_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10760296231151696","article-title":"Derivation and external validation of a risk prediction model for pulmonary embolism in patients with lung cancer: a large retrospective cohort study","volume":"29","author":"Zhu","year":"2023","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.003_bb0240","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17453674.2018.1427314","article-title":"Different competing risks models for different questions may give similar results in arthroplasty registers in the presence of few events","volume":"89","author":"Van Der Pas","year":"2018","journal-title":"Acta Orthop."},{"issue":"6","key":"10.1016\/j.thromres.2024.01.003_bb0245","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/jth.14774","article-title":"Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal d-dimer analysis: a prospective study","volume":"18","author":"Posch","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2024.01.003_bb0250","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/jth.14803","article-title":"Dynamic prediction modeling for cancer-associated venous thromboembolism","volume":"18","author":"van Es","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.01.003_bb0255","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jth.13218","article-title":"Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment","volume":"14","author":"Reitter","year":"2016","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:46Z","timestamp":1758736366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":51,"alternative-id":["S0049384824000033"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.01.003","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}